Beyond Air Dirección
Dirección controles de criterios 2/4
El CEO de Beyond Air's es Steve Lisi , nombrado en Jun 2017, tiene una permanencia de 6.83 años. compensación anual total es $6.88M, compuesta por 9.5% salario y 90.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 3.25% de las acciones de la empresa, por valor de $1.75M. La antigüedad media del equipo directivo y de la junta directiva es de 2.6 años y 6.7 años, respectivamente.
Información clave
Steve Lisi
Chief Executive Officer (CEO)
US$6.9m
Compensación total
| Porcentaje del salario del CEO | 9.5% |
| Permanencia del CEO | 6.9yrs |
| Participación del CEO | 3.2% |
| Permanencia media de la dirección | 2.7yrs |
| Promedio de permanencia en la Junta Directiva | 6.8yrs |
Actualizaciones recientes de la dirección
Recent updates
We're Keeping An Eye On Beyond Air's (NASDAQ:XAIR) Cash Burn Rate
Apr 05
Will Beyond Air (NASDAQ:XAIR) Spend Its Cash Wisely?
Dec 14Beyond Air presents pilot at-home study data; stock earlier snaps 7-day losing streak
Oct 17Beyond Air: Bottom Line Fundamentals Keep Buyers At Bay
Sep 08Beyond Air affiliate Beyond Cancer doses patient in phase 1 study of ultra-high concentration nitric oxide therapy
Aug 23Beyond Air reaches six-month high after $2.3M insider transactions
Jul 06Companies Like Beyond Air (NASDAQ:XAIR) Are In A Position To Invest In Growth
May 02Here's Why Shareholders May Want To Be Cautious With Increasing Beyond Air, Inc.'s (NASDAQ:XAIR) CEO Pay Packet
Feb 25Beyond Air: Follow The CEO And Buy The Dip
Dec 16Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$67m |
| Sep 30 2023 | n/a | n/a | -US$63m |
| Jun 30 2023 | n/a | n/a | -US$59m |
| Mar 31 2023 | US$7m | US$650k | -US$56m |
| Dec 31 2022 | n/a | n/a | -US$56m |
| Sep 30 2022 | n/a | n/a | -US$51m |
| Jun 30 2022 | n/a | n/a | -US$47m |
| Mar 31 2022 | US$6m | US$450k | -US$43m |
| Dec 31 2021 | n/a | n/a | -US$28m |
| Sep 30 2021 | n/a | n/a | -US$26m |
| Jun 30 2021 | n/a | n/a | -US$23m |
| Mar 31 2021 | US$2m | US$450k | -US$23m |
| Dec 31 2020 | n/a | n/a | -US$23m |
| Sep 30 2020 | n/a | n/a | -US$22m |
| Jun 30 2020 | n/a | n/a | -US$21m |
| Mar 31 2020 | US$1m | US$450k | -US$20m |
| Dec 31 2019 | n/a | n/a | -US$15m |
| Sep 30 2019 | n/a | n/a | -US$13m |
| Jun 30 2019 | n/a | n/a | -US$11m |
| Mar 31 2019 | US$3m | US$450k | -US$7m |
| Dec 31 2018 | n/a | n/a | -US$5m |
| Sep 30 2018 | n/a | n/a | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$10m |
| Mar 31 2018 | US$537k | US$130k | -US$11m |
| Dec 31 2017 | US$2m | US$163k | -US$18m |
Compensación vs. Mercado: La compensación total de Steve($USD6.88M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de Steve ha aumentado mientras la empresa no es rentable.
CEO
Steve Lisi (52 yo)
6.9yrs
Permanencia
US$6,876,550
Compensación
Mr. Steven Adam Lisi, also known as Steve, has been the Chief Executive Officer of Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.) since June 14, 2017. Mr. Lisi serves as Chief Executive Office...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Chairman of the Board | 6.9yrs | US$6.88m | 3.25% $ 1.9m | |
| Co-Founder | 13.3yrs | US$3.20m | 0.95% $ 565.1k | |
| Chief Operating Officer | 1.8yrs | US$1.13m | 0.14% $ 84.0k | |
| CFO, Principal Financial Officer & Principal Accounting Officer | 2.7yrs | US$1.13m | 0.040% $ 23.9k | |
| Head of Investor Relations | no data | sin datos | sin datos | |
| Head of Marketing | 3yrs | sin datos | sin datos | |
| Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board | 2.4yrs | sin datos | sin datos | |
| Chief Medical Officer | 1.2yrs | sin datos | 0.10% $ 60.1k | |
| Corporate Secretary | no data | US$643.57k | sin datos |
2.7yrs
Permanencia media
52yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de XAIR se considera experimentado (2.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Chairman of the Board | 7.3yrs | US$6.88m | 3.25% $ 1.9m | |
| Co-Founder | 13.3yrs | US$3.20m | 0.95% $ 565.1k | |
| Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board | 11.3yrs | sin datos | sin datos | |
| Independent Director | 6.3yrs | US$199.20k | 0.028% $ 16.3k | |
| Independent Director | 5.3yrs | US$324.60k | 6.49% $ 3.8m | |
| Independent Director | 7.3yrs | US$199.20k | 0.32% $ 186.7k | |
| Independent Director | 5.8yrs | US$199.20k | 0.032% $ 19.2k | |
| Member of Scientific Advisory Board | 6.3yrs | US$75.00k | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 6.8yrs | US$199.20k | 0.0095% $ 5.6k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
6.8yrs
Permanencia media
57yo
Promedio de edad
Junta con experiencia: La junta directiva de XAIR se considera experimentada (6.7 años de antigüedad promedio).